| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $21.2M | $7.0M | $13.1M |
| YoY Revenue Growth % | +201.1% | -46.2% | — |
| Gross Profit | -$9.6M | -$6.1M | — |
| Gross Margin % | -45.0% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$47.4M | -$41.3M | -$105.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$64.1M | -$51.6M | -$123.9M |
| EBITDA (Normalized) | -$47.0M | -$37.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$35.6M | -$38.2M | -$123.0M |
| Capital Expenditures (CapEx) | $603.0K | $4.8M | — |
| Free Cash Flow (FCF) | -$36.2M | -$42.9M | -$123.0M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $12.2M | $6.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $43.0M | -$40.8M | — |